In-silico based support for pharma to find new therapeutic options for a given indication and discover new indications for a given drug.

Delta4 is an AI Drug Discovery TechBio Company that focuses on discovering undetected relationships between drugs with a known safety profile and diseases to identify new indications. Delta4 utilizes Hyper-C (standing for Hyper Connectivity), a platform housing an enormous collection of algorithmic intelligence. It is operated by a team of highly skilled computational biologists that carefully analyze the data to produce unique insights and opportunities.

The platform feeds on big data and uses its algorithms and data integration to build molecular models which go through an iterative refinement process matching them to diseases. This sophisticated process utilizing thousands of pre-computed models effectively matches compounds to diseases for more efficient biological testing and clinical trials.

What we can do for you:

• find new indications for your existing drug
• find new drugs in a given indication
• identify and rank disease-modifying drug targets
• propose prognostic and predictive protein biomarkers
• provide specific background info on a drug effect/side effect
• generate a strong MoA-hypothesis

Several big names in the pharma space (e. g. Top-20 Pharma Company Germany, Top-20 Pharma Company Scandinavia, etc.) have put our high tech platform (Hyper-C) already to the test – with highest satisfaction!